Product/ Academy
The therapeutic effects of cannabinoids and the way of dosing
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by the mainstream in Europe and North America. Later, because people believed that its composition was unclear, quality control was difficult, and there were problems with abuse, it began to be gradually regulated and even banned. Since then, cannabis has become a plant that people are afraid
November 26th, 2024
